Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma

Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)22-26
Number of pages5
JournalEuropean Journal of Cancer
Volume34
Issue number3
Publication statusPublished - 1998

Bibliographical note

supplement

Research programs

  • EMC 04-01-DD-11-01

Cite this